Pfizer-BioNTech's COMIRNATY® Development Timeline

Description

Pfizer-BioNTech's COMIRNATY® development timeline, from the declaration of the COVID-19 pandemic to the U.S. Food and Drug Administration granting Early Use Authorization for COMIRNATY®.

Acknowledgements

References

1. World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. World Health Organization. Published March 11, 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 2. Pfizer Inc. Pfizer and BioNTech to Co-Develop potential COVID-19 vaccine. Pfizer. Published March 17, 2020. https://investors.pfizer.com/Investors/News/news-details/2020/Pfizer-and-BioNTech-to-Co-Develop-Potential-COVID-19-Vaccine-03-17-2020/default.aspx 3. Lewis LM, Badkar AV, Cirelli D, Combs R, Lerch TF. The Race to Develop the Pfizer-BioNTech COVID-19 Vaccine: From the Pharmaceutical Scientists' Perspective. J Pharm Sci. 2023;112(3):640-647. doi:10.1016/j.xphs.2022.09.014 4. MacMillan C. Emergency use authorization vs. full FDA approval: What’s the difference? Yale Medicine. Published March 7, 2022. https://www.yalemedicine.org/news/what-does-eua-mean 5. Pfizer Inc. BioNTech and Pfizer announce completion of dosing for first cohort of Phase 1/2 trial of COVID-19 vaccine candidates in Germany. Pfizer. Published April 29, 2020. https://www.pfizer.com/news/press-release/press-release-detail/biontech-and-pfizer-announce-completion-dosing-first-cohort 6. Pfizer Inc. Pfizer and BioNTech dose first participants in the U.S. as part of global COVID-19 mRNA vaccine development program. Pfizer. Published May 5, 2020. https://www.pfizer.com/news/press-release/press-release-detail/pfizer_and_biontech_dose_first_participants_in_the_u_s_as_part_of_global_covid_19_mrna_vaccine_development_program 7. Pfizer Inc. Pfizer and BioNTech conclude Phase 3 study of COVID-19 vaccine candidate, meeting all primary efficacy endpoints. Pfizer. Published November 18, 2020. https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-conclude-phase-3-study-covid-19-vaccine 8. Pfizer Inc. Pfizer and BioNTech to submit emergency use authorization request today to the U.S. FDA for COVID-19 vaccine. Pfizer. Published November 20, 2020. https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-submit-emergency-use-authorization 9. Pfizer Inc. Pfizer and BioNTech celebrate historic first authorization in the U.S. of vaccine to prevent COVID-19. Pfizer. Published December 11, 2020. https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-celebrate-historic-first-authorization

Get started with this template for free

Don’t start from scratch.

Create professional scientific illustrations quickly and easily, even without any design expertise

Get started with a huge library of editable icons and templates such as common biological pathways, anatomy, or genetics.
Create figures that effectively communicate your research in half the time using our editable icons.
Use our PDB tool to quickly generate and customize protein structures

Get started now